Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients

被引：50

作者：

Regent, Alexis ^{[1
]}

Redeker, Serge ^{[2
]}

Deroux, Alban ^{[3
]}

Kieffer, Pierre ^{[4
]}

Ly, Kim Heang ^{[5
]}

Dougados, Maxime ^{[6
]}

Liozon, Eric ^{[5
]}

Larroche, Claire ^{[7
]}

Guillevin, Loic ^{[1
]}

Bouillet, Laurence ^{[3
]}

Espitia, Olivier ^{[8
]}

Costedoat-Chalumeau, Nathalie ^{[1
]}

Soubrier, Martin ^{[9
]}

Brihaye, Benoit ^{[10
]}

Lifermann, Francois ^{[11
]}

Lefevre, Guillaume ^{[12
]}

Puechal, Xavier ^{[13
,14
]}

Mouthon, Luc ^{[13
,14
]}

Toussirot, Eric ^{[15
]}

机构：

[1] Univ Paris 05, Hop Cochin, APHP, Ctr Reference Malad Autoimmunes & Syst Rares,Serv, Paris, France

[2] Ctr Hosp Abbeville, Serv Med Interne, Abbeville, France

[3] Univ Grenoble Alpes, Serv Med Interne, CHU Grenoble, Grenoble, France

[4] Ctr Hosp Gen Mulhouse, Serv Med Interne, Mulhouse, France

[5] CHU Limoges, Serv Med Interne, Limoges, France

[6] Univ Paris 05, Hop Cochin, APHP,INSERM,PRES Sorbonne Paris Cite, Clin Epidemiol & Biostat,Dept Rheumatol,U1153, Paris, France

[7] Hop Avicenne, Serv Med Interne, Avicenne, France

[8] Hop Hotel Dieu, Serv Med Interne, Paris, France

[9] CHU Clermont Ferrand, Serv Rhumatol, Clermont Ferrand, France

[10] Hop St Quentin, Serv Med Interne & Med Polyvalente, Paris, France

[11] CH Dax, Serv Med Interne, Dax, France

[12] Hop Claude Huriez, Serv Med Interne, Paris, France

[13] Univ Paris 05, Paris, France

[14] Hop Cochin, APHP, Serv Med Interne, Ctr Reference Malad Autoimmunes & Syst Rares, Paris, France

[15] CHRU, INSERM CIC 1431, FHU INCREASE,Serv Rhumatol, Ctr Invest Clin Biotherapie, Paris, France

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 08期

关键词：

GIANT CELL ARTERITIS; TOCILIZUMAB; BIOLOGICAL THERAPY; LARGE-VESSEL VASCULITIS; INTERLEUKIN-6;

D O I：

10.3899/jrheum.151252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA). Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. Results. TCZ was effective in all but 6 patients, who still had mild symptoms. Mean glucocorticoid dose was tapered. One patient died and 3 patients had to stop TCZ therapy because of severe adverse events. Twenty-three patients stopped treatment; 8 of these experienced relapses after a mean of 3.5 +/- 1.3 months. Conclusion. TCZ is effective in GCA. However, side effects occur. Whether this treatment has only a suspensive effect remains to be determined.

引用

页码：1547 / 1552

页数：6

共 14 条

[1] Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial [J].

Collinson, Neil ;

Tuckwell, Katie ;

Habeck, Frank ;

Chapman, Monique ;

Klearman, Micki ;

Stone, John H. .

INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2015, 2015

[2] PRODUCTION OF INTERLEUKIN-6 BY GRANULOMAS OF GIANT-CELL ARTERITIS [J].

EMILIE, D ;

LIOZON, E ;

CREVON, MC ;

LAVIGNAC, C ;

PORTIER, A ;

LIOZON, F ;

GALANAUD, P .

HUMAN IMMUNOLOGY, 1994, 39 (01) :17-24

[3] Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial [J].

Hoffman, Gary S. ;

Cid, Maria C. ;

Rendt-Zagar, Karen E. ;

Merkel, Peter A. ;

Weyand, Cornelia M. ;

Stone, John H. ;

Salvarani, Carlo ;

Xu, Weichun ;

Visvanathan, Sudha ;

Rahman, Mahboob U. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (09) :621-630

[4]

HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122

[5] Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients [J].

Loricera, Javier ;

Blanco, Ricardo ;

Hernandez, Jose L. ;

Castaneda, Santos ;

Mera, Antonio ;

Perez-Pampin, Eva ;

Peiro, Enriqueta ;

Humbria, Alicia ;

Calvo-Alen, Jaime ;

Aurrecoechea, Elena ;

Narvaez, Javier ;

Sanchez-Andrade, Amalia ;

Vela, Paloma ;

Diez, Elvira ;

Mata, Cristina ;

Lluch, Pau ;

Moll, Concepcion ;

Hernandez, Inigo ;

Calvo-Rio, Vanesa ;

Ortiz-Sanjuan, Francisco ;

Gonzalez-Vela, Carmen ;

Pina, Trinitario ;

Gonzalez-Gay, Miguel A. .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) :717-723

[6] Interleukin-1 blockade in refractory giant cell arteritis [J].

Ly, Kim-Heang ;

Stirnemann, Jerome ;

Liozon, Eric ;

Michel, Marc ;

Fain, Olivier ;

Fauchais, Anne-Laure .

JOINT BONE SPINE, 2014, 81 (01) :76-78

[7] Adjunctive methotrexate for treatment of giant cell arteritis -: An individual patient data meta-analysis [J].

Mahr, Alfred D. ;

Jover, Juan A. ;

Spiera, Robert F. ;

Hernandez-Garcia, Cesar ;

Fernandez-Gutierrez, Benjamin ;

LaValley, Michael P. ;

Merkel, Peter A. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (08) :2789-2797

[8] Relapses and Recurrences in Giant Cell Arteritis A Population-Based Study of Patients With Biopsy-Proven Disease From Northwestern Spain [J].

Martinez-Lado, Luciana ;

Calvino-Diaz, Carolina ;

Pineiro, Angela ;

Dierssen, Trinidad ;

Vazquez-Rodriguez, Tomas R. ;

Miranda-Filloy, Jose A. ;

Lopez-Diaz, Maria J. ;

Blanco, Ricardo ;

Llorca, Javier ;

Gonzalez-Gay, Miguel A. .

MEDICINE, 2011, 90 (03) :186-193

[9] The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab [J].

Mayrbaeurl, B. ;

Hinterreiter, M. ;

Burgstaller, S. ;

Windpessl, M. ;

Thaler, J. .

CLINICAL RHEUMATOLOGY, 2007, 26 (09) :1597-1598

[10] Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes [J].

Proven, A ;

Gabriel, SE ;

Orces, C ;

O'Fallon, WM ;

Hunder, GG .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (05) :703-708

← 1 2 →